Suppr超能文献

多维元素和抗氧化剂的使用与被诊断患有结直肠癌的女性和男性的死亡率之间的关联。

The Associations of Multivitamin and Antioxidant Use With Mortality Among Women and Men Diagnosed With Colorectal Cancer.

机构信息

Community and Population Health Research, Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute, Los Angeles, CA, USA.

Flatiron Health, New York, NY, USA.

出版信息

JNCI Cancer Spectr. 2022 Jul 1;6(4). doi: 10.1093/jncics/pkac041.

Abstract

BACKGROUND

Colorectal cancer survivors often use multivitamins and other over-the-counter dietary supplements, but evidence is limited regarding their potential associations with mortality.

METHODS

This prospective analysis included women and men from the Cancer Prevention Study-II Nutrition Cohort who were cancer-free at baseline (1992 or 1993) and diagnosed with colorectal cancer through June 2015. Detailed information on multivitamin use, vitamin C supplements, and vitamin E supplements was self-reported on questionnaires at baseline, in 1997, and every 2 years thereafter. Pre- and postdiagnosis data were available for 3176 and 2006 colorectal cancer survivors, respectively, among whom 2116 (648 from colorectal cancer) and 1256 (242 from colorectal cancer) died. Multivariable-adjusted Cox proportional hazards regression models examined associations. All statistical tests were 2-sided.

RESULTS

Among colorectal cancer survivors, 49.7% and 58.5% reported multivitamin use before and after diagnosis, respectively (vitamin C use before and after diagnosis: 27.8% and 28.1%; vitamin E use before and after diagnosis: 27.5% and 29.4%, respectively). There were no statistically significant associations of pre- or postdiagnosis multivitamin use with all-cause, colorectal cancer-specific, or noncolorectal cancer mortality. Vitamin C was also not associated with any mortality outcomes. However, prediagnosis vitamin E use was associated with a non-statistically significant increased risk of all-cause mortality (multivariable adjusted hazard ratio = 1.08, 95% confidence intervals = 0.96 to 1.23) and all other noncolorectal cancer mortality (multivariable adjusted hazard ratio = 1.13, 95% confidence intervals = 0.97 to 1.31).

CONCLUSIONS

These results suggest that multivitamin use before or after diagnosis is not associated with mortality in colorectal cancer survivors. However, vitamin E use may be associated with increased risk of mortality and merits further investigation.

摘要

背景

结直肠癌幸存者经常使用多种维生素和其他非处方膳食补充剂,但关于它们与死亡率潜在关联的证据有限。

方法

本前瞻性分析纳入了癌症预防研究-II 营养队列中的女性和男性,他们在基线时(1992 年或 1993 年)无癌症,并且在 2015 年 6 月之前通过结直肠癌诊断。在基线、1997 年和此后每 2 年的问卷中,自我报告了多种维生素使用、维生素 C 补充剂和维生素 E 补充剂的详细信息。分别为 3176 名和 2006 名结直肠癌幸存者提供了发病前和发病后的数据,其中 2116 名(结直肠癌患者 648 名)和 1256 名(结直肠癌患者 242 名)死亡。多变量调整的 Cox 比例风险回归模型检查了相关性。所有统计检验均为双侧检验。

结果

在结直肠癌幸存者中,分别有 49.7%和 58.5%报告了发病前和发病后使用多种维生素(发病前和发病后使用维生素 C:27.8%和 28.1%;发病前和发病后使用维生素 E:27.5%和 29.4%)。发病前或发病后使用多种维生素与全因、结直肠癌特异性或非结直肠癌死亡率均无统计学显著关联。维生素 C 也与任何死亡率结果无关。然而,发病前使用维生素 E 与全因死亡率增加的非统计学显著风险相关(多变量调整后的危险比=1.08,95%置信区间=0.96 至 1.23)和所有其他非结直肠癌死亡率增加的非统计学显著风险(多变量调整后的危险比=1.13,95%置信区间=0.97 至 1.31)。

结论

这些结果表明,结直肠癌幸存者在诊断前后使用多种维生素与死亡率无关。然而,维生素 E 的使用可能与死亡率增加有关,值得进一步研究。

相似文献

10
Drugs for preventing lung cancer in healthy people.用于预防健康人群肺癌的药物。
Cochrane Database Syst Rev. 2020 Mar 4;3(3):CD002141. doi: 10.1002/14651858.CD002141.pub3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验